Study on the treatment of pancreatic cancer by the expansion of magic medicine sodium cantharidate

On the evening of the 26th, Shanghai magic pharmaceutical investment management Co., Ltd released the announcement on the important progress of the research on the anticancer mechanism and anticancer effect of sodium cantharidate, which is noteworthy: the announcement said that the sodium cantharidate product has been on the market for many years, this study is only for the re evaluation after the market and the exploration of the expansion of indications, this expansion exploration of indications is aimed at the pancreatic cancer The treatment research is still in the stage of in vitro cell test and animal body test, which belongs to the early stage of research, and the sample size of animal test is small, whether it is effective for human body needs further clinical trials to prove 1 In 2017, Shanghai magic pharmaceutical carried out in vitro screening experiment of anti-tumor spectrum of sodium cantharidate, in vivo anti pancreatic cancer experiment of sodium cantharidate, anti primary human pancreatic cancer activity experiment of sodium cantharidate, anti-cancer mechanism and target research of sodium cantharidate, and made important progress in recent years 2 The conclusions of this series of studies further verify the anti-tumor mechanism of sodium cantharidate, and will guide the expansion direction of anti-tumor indications of sodium cantharidate products in the future The following is the specific content: This article is reprinted by yaozhi.com The copyright belongs to the original author The purpose of reprinting is to transmit more information and does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.